Don’t let Sacramento take away what’s working for Californians.

Thousands of Californians have lost access to vital GLP-1 medications. These aren’t lifestyle drugs. They are medically necessary treatments. Tell your Representatives to restore Medi-Cal coverage for GLP-1s.

Stay Updated

Nearly 15 million Californians on Medi-Cal, ~38% of the state.

GLP-1s are necessary medical treatments, not a luxury.

Everyone, regardless of income, deserves access to the treatments they need.

What’s at Stake

In 2023, Medi-Cal began covering GLP-1s, metabolic medications that reduce the risk of type 2 diabetes, cardiovascular disease, chronic kidney disease, obstructive sleep apnea, fatty liver disease, and heart failure. However, in 2026, Governor Newsom made the decision to cut coverage of these medications.

Our Coalition

Californians for GLP-1 Access is a growing coalition of patient advocates, health equity organizations, and medical professionals.

Learn More

Let’s restore access to GLP-1s. For our health. For our future.

Together, we can ensure that California remains a leader in health, compassion, and common sense.

Take Action